These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33621432)

  • 1. Inhibition of HSP90 causes morphological variation in the invasive ant Cardiocondyla obscurior.
    Schrader L; Winter M; Errbii M; Delabie J; Oettler J; Gadau J
    J Exp Zool B Mol Dev Evol; 2021 Jun; 336(4):333-340. PubMed ID: 33621432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
    Karkoulis PK; Stravopodis DJ; Voutsinas GE
    Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons.
    Specchia V; Piacentini L; Tritto P; Fanti L; D'Alessandro R; Palumbo G; Pimpinelli S; Bozzetti MP
    Nature; 2010 Feb; 463(7281):662-5. PubMed ID: 20062045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HSP90 attenuates angiotensin II-induced adventitial remodelling via suppression of mitochondrial fission.
    Huang G; Cong Z; Wang X; Yuan Y; Xu R; Lu Z; Wang X; Qi J
    Cardiovasc Res; 2020 Apr; 116(5):1071-1084. PubMed ID: 31346611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypic variability of Arabidopsis thaliana seedlings as a result of inhibition of Hsp90 chaperones].
    Kozeko LE
    Tsitol Genet; 2013; 47(2):18-33. PubMed ID: 23745360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to thermotherapy.
    Cui XB; Yu ZY; Wang W; Zheng YQ; Liu W; Li LX
    Integr Cancer Ther; 2012 Mar; 11(1):61-7. PubMed ID: 21498475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
    Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
    J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes.
    Wang Y; McAlpine SR
    Chem Commun (Camb); 2015 Jan; 51(8):1410-3. PubMed ID: 25333923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis.
    Kim J; Jang SW; Park E; Oh M; Park S; Ko J
    J Mol Cell Cardiol; 2014 Jul; 72():157-67. PubMed ID: 24650873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
    Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines.
    Ghadban T; Jessen A; Reeh M; Dibbern JL; Mahner S; Mueller V; Wellner UF; Güngör C; Izbicki JR; Vashist YK
    Int J Mol Med; 2016 Oct; 38(4):1296-302. PubMed ID: 27498942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Induced HSP90 Inhibition Alleviates Pain in Monoarthritic Rats and Alters the Expression of New Putative Pain Players at the DRG.
    Nascimento DSM; Potes CS; Soares ML; Ferreira AC; Malcangio M; Castro-Lopes JM; Neto FLM
    Mol Neurobiol; 2018 May; 55(5):3959-3975. PubMed ID: 28550532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
    Stravopodis DJ; Margaritis LH; Voutsinas GE
    Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective role of HSP90 chaperone in gamma-irradiated Arabidopsis thaliana seeds.
    Kozeko L; Talalaiev O; Neimash V; Povarchuk V
    Life Sci Space Res (Amst); 2015 Jul; 6():51-8. PubMed ID: 26256628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 90 inhibitors induce functional inhibition of human natural killer cells in a dose-dependent manner.
    Huyan T; Li Q; Dong DD; Yang H; Zhang J; Huang QS; Yin DC; Shang P
    Immunopharmacol Immunotoxicol; 2016; 38(2):77-86. PubMed ID: 26642940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP90 Inhibition and Cellular Stress Elicits Phenotypic Plasticity in Hematopoietic Differentiation.
    Lawag AA; Napper JM; Hunter CA; Bacon NA; Deskins S; El-Hamdani M; Govender SL; Koc EC; Sollars VE
    Cell Reprogram; 2017 Oct; 19(5):311-323. PubMed ID: 28910138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.